JY
ANRO icon

Jeff Yass’s Alto Neuroscience ANRO Stock Holding History

Jeff Yass’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$736K Buy
27,900
+12,200
+78% +$282K ﹤0.01% 8980
2026
Q1 		$353K Buy
+15,700
New +$291K ﹤0.01% 10508
2025
Q1 		– Sell
-41,500
Closed -$176K – 13610
2024
Q4 		$176K Buy
+41,500
New +$259K ﹤0.01% 10868

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jeff Yass's ANRO Position: Q2 2026 in Review

Jeff Yass reduced its Alto Neuroscience (ANRO) stake by 97% in Q2 2026, selling an estimated $5.33M and leaving 7,998 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #11827.

Jeff Yass first reported a position in ANRO in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.36M in Q1 2026. 113 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Jeff Yass held 7,998 shares of Alto Neuroscience worth $211K as of Q2 2026.
  • Jeff Yass sold 230,500 Alto Neuroscience shares in Q2 2026, an estimated $5.33M.
  • Alto Neuroscience made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11827 holding.
  • Jeff Yass first reported a position in Alto Neuroscience in Q4 2024 and has held it in 7 quarters since.
  • Jeff Yass's Alto Neuroscience position peaked at $5.36M in Q1 2026.
  • 113 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.